Editorial Independence

The Cancer News is an independent publication supported by Binaytara, a 501(c)(3) global oncology nonprofit. Our editorial team makes all content decisions (including topic selection, coverage, and conclusions) without influence from Binaytara’s partnerships or sponsors. Binaytara organizes oncology educational conferences compliant with American Board of Internal Medicine (ABIM) accreditation standards, and certain contributing authors to The Cancer News may have presented at or attended one of these conferences.

Funding Transparency

Binaytara is a nonprofit publisher. As a matter of policy, Binaytara will sell advertising space in The Cancer News when the inclusion of advertising does not interfere with the mission or objective of Binaytara or The Cancer News. To maintain integrity, advertising interest cannot influence educational decisions or educational content. The decision to sell advertising space is made independently of and without reference to specific editorial content.

Advertising Separation

Advertising is clearly identified as such and separated from editorial content, and does not influence coverage decisions.

Conflict of Interest Policy

All contributors to The Cancer News are required to disclose any financial or professional relationships that could be perceived as influencing their content. Relevant disclosures are noted within articles.

No Product Endorsement

The Cancer News does not endorse specific drugs, treatments, devices, or products. Any mention of specific drugs, treatments, devices or products in editorial content are for medical education purposes and supported by evidence, and not as promotion.

Contact for Ethics Concerns

If you have concerns about editorial integrity, please contact us at [email protected].